XGN CIK: 1274737

Exagen Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
113
FY22:
72.6
FY23:
47.8
FY24:
36.5
FY25:
48.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
10.7
FY22:
13.6
FY23:
9.10
FY24:
8.23
FY25:
9.13
Total assets
Change from FY21 to FY25
millions USD
FY21:
123
FY22:
86.2
FY23:
56.9
FY24:
44.7
FY25:
58.0

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
9.32
FY22:
9.62
FY23:
11.9
FY24:
13.5
FY25:
14.2
(negative)
Change from FY21 to FY25
millions USD
FY21:
29.2
FY22:
34.1
FY23:
22.3
FY24:
21.6
FY25:
26.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
84.9
FY22:
42.5
FY23:
22.7
FY24:
9.54
FY25:
17.4
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
123
FY22:
86.2
FY23:
56.9
FY24:
44.7
FY25:
58.0

All amounts in millions USD Data source:SEC EDGAR